Abstract
UVA1 phototherapy, a new therapeutic approach, has recently been shown good efficacy in the treatment of palmoplantar pustulosis (PPP). The purpose of this study was to compare the efficacy of UVA1 and narrowband UVB (NB-UVB) therapy in the treatment of PPP. Patients with PPP were randomly assigned to either UVA1 or NB-UVB therapy according to a left-right randomization table. Both treatments were performed three times weekly for up to 30 sessions. Clinical evaluation was based on the Palmoplantar Pustular Psoriasis Area and Severity Index (PPPASI) score. Totally 64 patients completed the study. Both UVA1 and NB-UVB therapy showed a statistically significant reduction of PPPASI score compared with the baseline value at the end of the treatment period (P < 0.05). There was a significantly greater mean reduction of PPPASI score in the UVA1 treated group when compared to the NB-UVB treated patients at 30 sessions (6.0 ± 2.4 vs. 4.4 ± 1.4, P < 0.05). No phototoxic reaction or bullous changes were observed in either group. Both NB-UVB and UVA1 phototherapy of PPP resulted in significant improvement. UVA1 phototherapy was more effective than NB-UVB irradiation in the treatment of PPP.
Similar content being viewed by others
References
Hellgren L, Mobacken H (1971) Pustulosis palmaris et plantaris prevalence, clinical observations and prognosis. Acta Derm Venereol 51:284–288
Brunasso AM, Puntoni M, Aberer W, Delfino C, Fancelli L, Massone C (2013) Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study. Br J Dermatol 168:1243–1251
Kubota K, Kamijima Y, Sato T, Ooba N, Koide D, Iizuka H, Nakagawa H (2015) Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database. BMJ Open 5:e006450
Pettey AA, Balkrishnan R, Rapp SR, Fleischer AB, Feldman SR (2003) Patients with palmoplantar psoriasis have more physical disability and discomfort than patients with otherforms of psoriasis: implications for clinical practice. J Am Acad Dermatol 49:271–275
Farley E, Masrour S, McKey J, Menter A (2009) Palmoplantar psoriasis: a phenotypical and clinical review with introduction of a new quality-of-life assessment tool. J Am Acad Dermatol 60:1024–1031
Mrowietz U, van de Kerkhof PC (2011) Management of palmoplantar pustulosis: do we need to change? Br J Dermatol 164:942–946
Reich K, Graff O, Mehta N (2016) Oral alitretinoin treatment in patients with palmoplantar pustulosis inadequately responding to standard topical treatment: a randomized phase II study. Br J Dermatol 174:1277–1281
Layton AM, Sheehan-Dare R, Cunliffe WJ (1991) A double-blind, placebo-controlled trial of topical PUVA in persistent palmoplantar pustulosis. Br J Dermatol 124:581–584
Fumimori T, Tsuruta D, Kawakami T, Ohata C, Furumura M, Hashimoto T (2013) Effect of monochromatic excimer light on palmoplantar pustulosis: a clinical study performed in a private clinic by a dermatological specialist. J Dermatol 40:1004–1007
Lim HL, Chong WS (2012) Recalcitrant eosinophilic pustular folliculitis of Ofuji with palmoplantar pustulosis: dramatic response to narrowband UVB phototherapy. Photodermatol Photoimmunol Photomed 28:219–221
Nisticò SP, Saraceno R, Chiricozzi A, Giunta A, Di Stefani A, Zerbinati N (2013) UVA-1 Laser in the treatment of palmoplantar pustular psoriasis. Photomed Laser Surg 31:434–438
Su LN, Xu X, Tang L, Yu N, Ding YF (2016) UVA1 phototherapy in the treatment of palmoplantar pustulosis: a pilot prospective study. Lasers Med Sci. doi:10.1007/s10103-016-2031-7
Otsuka A, Miyachi Y, Kabashima K (2011) Narrowband ultraviolet B phototherapy decreased CCR4+ CD8+ T cells in a patient with palmoplantar pustulosis. J Eur Acad Dermatol Venereol 25:495–496
Bhushan M, Burden AD, McElhone K, James R, Vanhoutte FP, Griffiths CE (2001) Oral liarozole in the treatment of palmoplantar pustular psoriasis: a randomized, double-blind, placebo-controlled study. Br J Dermatol 145:546–553
Gambichler T, Terras S, Kreuter A (2013) Treatment regimens, protocols, dosage, and indications for UVA1 phototherapy: facts and controversies. Clin Dermatol 31:438–454
Suh KS, Kang JS, Baek JW, Kim TK, Lee JW, Jeon YS, Jang MS, Kim ST (2010) Efficacy of ultraviolet A1 phototherapy in recalcitrant skin diseases. Ann Dermatol 22:1–8
Kawada A, Matsuda H, Oiso N (2013) Efficacy and safety of targeted narrowband ultraviolet B therapy using a flat-type fluorescent lamp for the treatment of palmoplantar pustulosis. J Dermatol 40:754–755
Sevrain M, Richard MA, Barnetche T, Rouzaud M, Villani AP, Paul C, Beylot-Barry M, Jullien D, Aractingi S, Aubin F, Joly P, Le Maitre M, Cantagrel A, Ortonne JP, Misery L (2014) Treatment for palmoplantar pustular psoriasis: systematic literature review, evidence-based recommendations and expert opinion. J Eur Acad Dermatol Venereol 28(Suppl 5):13–16
Morita A, Werfel T, Stege H, Ahrens C, Karmann K, Grewe M, Grether-Beck S, Ruzicka T, Kapp A, Klotz LO, Sies H, Krutmann J (1997) Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet—a radiation phototherapy. J Exp Med 186:1763–1768
York NR, Jacobe HT (2010) UVA1 phototherapy: a review of mechanism and therapeutic application. Int J Dermatol 49:623–630
Godar DE (1999) UVA1 radiation triggers two different final apoptotic pathways. J Investig Dermatol 112:3–12
Breuckmann F, von Kobyletzki G, Avermaete A, Kreuter A, Altmeyer P (2002) Efficacy of ultraviolet A1 phototherapy on the expression of bcl-2 in atopic dermatitis and cutaneous T-cell lymphoma in vivo: a comparison study. Photodermatol Photoimmunol Photomed 18:217–222
El-Mofty M, Mostafa WZ, Yousef R, Abdel Halim MR, El Hawary M, Abdel Kader H, Assaad S, Ghannam BB (2014) Broadband ultraviolet a in the treatment of psoriasis vulgaris: a randomized controlled trial. Int J Dermatol 53:1157–1164
Skov L, Hansen H, Allen M, Villadsen L, Norval M, Barker JN, Simon J, Baadsgaard O (1998) Contrasting effects of ultraviolet A1 and ultraviolet B exposure on the induction of tumour necrosis factor-alpha in human skin. Br J Dermatol 138:216–220
Krutmann J, Grewe M (1995) Involvement of cytokines, DNA damage, and reactive oxygen intermediates in ultraviolet radiation-induced modulation of intercellular adhesion molecule-1 expression. J Investig Dermatol 105:67S–70S
Szegedi A, Simics E, Aleksza M, Horkay I, Gaál K, Sipka S, Hunyadi J, Kiss E (2005) Ultraviolet-A1 phototherapy modulates Th1/Th2 and Tc1/Tc2 balance in patients with systemic lupus erythematosus. Rheumatology (Oxford) 44:925–931
Acknowledgments
This study was supported by grant from the Natural Science Foundation of Shanghai Municipal Commission of Health and Family Planning (201640188).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics statement
This study was approved by the Ethics Committee of Huashan Hospital and conducted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Electronic supplementary material
ESM 1
(XLSX 13 kb)
Rights and permissions
About this article
Cite this article
Su, Ln., Ren, J., Cheng, Sm. et al. UVA1 vs. narrowband UVB phototherapy in the treatment of palmoplantar pustulosis: a pilot randomized controlled study. Lasers Med Sci 32, 1819–1823 (2017). https://doi.org/10.1007/s10103-017-2280-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10103-017-2280-0